Human cytomegalovirus is protected from inactivation by reversible binding to villous trophoblasts

Biology of Reproduction

Volumn 85, Issue 1, 2011, Pages 198-207

  Davey, Ashley ^a   Eastman, Lauren ^a   Hansraj, Priyanka ^b   Hemmings, Denise G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Fetal; Human cytomegalovirus; Infection; Maternal; Microvilliation; Placenta; Pregnancy; Syncytiotrophoblast; Viral reservoir

Indexed keywords

IMMUNOGLOBULIN; PROTEOHEPARAN SULFATE;

ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOTROPHOBLAST; FEMALE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; INOCULATION; MICROBIAL DEGRADATION; MOLECULAR INTERACTION; NONHUMAN; PH; PLACENTA; PRIORITY JOURNAL; SYNCYTIOTROPHOBLAST; VIRUS CULTURE; VIRUS INACTIVATION;

ANTIBODIES, NEUTRALIZING; CACO-2 CELLS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN; HOST-PATHOGEN INTERACTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOGLOBULINS, INTRAVENOUS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; TROPHOBLASTS; VIRUS ATTACHMENT; VIRUS INACTIVATION;

HUMAN HERPESVIRUS 5;

EID: 79960146504     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.110.088567     Document Type: Article

References (59)

1. Demmler GJ. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 1991; 13:315-329.
2. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001; 344:1366-1371.
3. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD, Veren DA, Page F, Alford CA. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 1986; 256:1904-1908.
4. Ahlfors K, Ivarsson SA, Harris S. Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature. Scand J Infect Dis 1999; 31:443-457.
5. Williamson WD, Demmler GJ, Percy AK, Catlin FI. Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics 1992; 90:862-866.
6. Porath A, McNutt RA, Smiley LM, Weigle KA. Effectiveness and cost benefit of a proposed live cytomegalovirus vaccine in the prevention of congenital disease. Rev Infect Dis 1990; 12:31-40.
7. Seale H, Booy R, MacIntyre CR. Trends in hospitalizations for diagnosed congenital cytomegalovirus in infants and children in Australia. BMC Pediatr 2009; 9:7.
8. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992; 326:663-667.
9. Lazzarotto T, Gabrielli L, Lanari M, Guerra B, Bellucci T, Sassi M, Landini MP. Congenital cytomegalovirus infection: recent advances in the diagnosis of maternal infection. Hum Immunol 2004; 65:410-415.
10. Revello MG, Zavattoni M, Sarasini A, Percivalle E, Simoncini L, Gerna G. Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. J Infect Dis 1998; 177:1170-1175.
11. Stagno S. In: Remington JS, Klein JO (eds.), Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: W.B. Saunders Co.; 2001:389- 424.
12. Griffith BP, McCormick SR, Fong CK, Lavallee JT, Lucia HL, Goff E. The placenta as a site of cytomegalovirus infection in guinea pigs. J Virol 1985; 55:402-409.
13. Guleria I, Pollard JW. The trophoblast is a component of the innate immune system during pregnancy. Nat Med 2000; 6:589-593.
14. Bakardjiev AI, Theriot JA, Portnoy DA. Listeria monocytogenes traffics from maternal organs to the placenta and back. PLoS Pathog 2006; 2:e66.
15. Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996; 272:1502-1504.
16. Lucchi NW, Koopman R, Peterson DS, Moore JM. Plasmodium falciparum-infected red blood cells selected for binding to cultured syncytiotrophoblast bind to chondroitin sulfate A and induce tyrosine phosphorylation in the syncytiotrophoblast. Placenta 2006; 27:384-394.
17. Constantin CM, Masopust D, Gourley T, Grayson J, Strickland OL, Ahmed R, Bonney EA. Normal establishment of virus-specific memory CD8 T cell pool following primary infection during pregnancy. J Immunol 2007; 179:4383-4389.
18. Medawar P. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol 1953; 7:320-338.
19. Trowsdale J, Betz AG. Mother's little helpers: mechanisms of maternalfetal tolerance. Nat Immunol 2006; 7:241-246.
20. Goff E, Griffith BP, Booss J. Delayed amplification of cytomegalovirus infection in the placenta and maternal tissues during late gestation. Am J Obstet Gynecol 1987; 156:1265-1270.
21. Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002; 15:680-715.
22. Harrison CJ, Myers MG. Relation of maternal CMV viremia and antibody response to the rate of congenital infection and intrauterine growth retardation. J Med Virol 1990; 31:222-228.
23. Pereira L, Maidji E, McDonagh S, Genbacev O, Fisher S. Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity. J Virol 2003; 77:13301-13314.
24. Kumazaki K, Ozono K, Yahara T, Wada Y, Suehara N, Takeuchi M, Nakayama M. Detection of cytomegalovirus DNA in human placenta. J Med Virol 2002; 68:363-369.
25. McDonagh S, Maidji E, Chang HT, Pereira L. Patterns of human cytomegalovirus infection in term placentas: a preliminary analysis. J Clin Virol 2006; 35:210-215.
26. Muhlemann K, Miller RK, Metlay L, Menegus MA. Cytomegalovirus infection of the human placenta: an immunocytochemical study. Hum Pathol 1992; 23:1234-1237.
27. Fisher S, Genbacev O, Maidji E, Pereira L. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol 2000; 74:6808-6820.
28. Hemmings DG, Kilani R, Nykiforuk C, Preiksaitis J, Guilbert LJ. Permissive cytomegalovirus infection of primary villous term and first trimester trophoblasts. J Virol 1998; 72:4970-4979.
29. Ziyaeyan M, Alborzi A, Abbasian A, Kalani M, Moravej A, Nasiri J, Amiri A, Hashemi N, Sefiddashti F. Detection of HCMV DNA in placenta, amniotic fluid and fetuses of seropositive women by nested PCR. Eur J Pediatr 2007; 166:723-726.
30. Compton T, Nowlin DM, Cooper NR. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology 1993; 193:834-841.
31. Feire AL, Koss H, Compton T. Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrinlike domain. Pro Natl Acad Sci U S A 2004; 101:15470-15475.
32. Morrish DW, Dakour J, Li H, Xiao J, Miller R, Sherburne R, Berdan RC, Guilbert LJ. In vitro cultured human term cytotrophoblast: a model for normal primary epithelial cells demonstrating a spontaneous differentiation program that requires EGF for extensive development of syncytium. Placenta 1997; 18:577-585.
33. Yui J, Garcia-Lloret M, Brown AJ, Berdan RC, Morrish DW, Wegmann TG, Guilbert LJ. Functional, long-term cultures of human term trophoblasts purified by column-elimination of CD9 expressing cells. Placenta 1994; 15:231-246.
34. Douglas GC, King BF. Differentiation of human trophoblast cells in vitro as revealed by immunocytochemical staining of desmoplakin and nuclei. J Cell Sci 1990; 96(pt 1):131-141.
35. Collett A, Walker D, Sims E, He YL, Speers P, Ayrton J, Rowland M, Warhurst G. Influence of morphometric factors on quantitation of paracellular permeability of intestinal epithelia in vitro. Pharm Res 1997; 14:767-773.
36. Osborn JE, Walker DL. Enhancement of infectivity of murine cytomegalovirus in vitro by centrifugal inoculation. J Virol 1968; 2:853-858.
37. Chou SW, Scott KM. Rapid quantitation of cytomegalovirus and assay of neutralizing antibody by using monoclonal antibody to the major immediate-early viral protein. J Clin Microbiol 1988; 26:504-507.
38. Compton T, Nepomuceno RR, Nowlin DM. Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. Virology 1992; 191:387-395.
39. Zaia JA. Prevention and treatment of cytomegalovirus pneumonia in transplant recipients. Clin Infect Dis 1993; 17(suppl 2):S392-S399.
40. Ryckman BJ, Jarvis MA, Drummond DD, Nelson JA, Johnson DC. Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J Virol 2006; 80:710-722.
41. Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 1996; 70:78-83.
42. Hodgkin PD, Scalzo AA, Swaminathan N, Price P, Shellam GR. Murine cytomegalovirus binds reversibly to mouse embryo fibroblasts: implications for quantitation and explanation of centrifugal enhancement. J Virol Methods 1988; 22:215-230.
43. Ornoy A, Diav-Citrin O. Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod Toxicol 2006; 21:399- 409.
44. Chan G, Hemmings DG, Yurochko AD, Guilbert LJ. Human cytomegalovirus-caused damage to placental trophoblasts mediated by immediate early gene-induced tumor necrosis factor-alpha. Am J Pathol 2002; 161:1371-1381.
45. Nigro G, Adler SP, La Torre R, Best AM. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005; 353:1350-1362.
46. Schleiss MR. The role of the placenta in the pathogenesis of congenital cytomegalovirus infection: is the benefit of cytomegalovirus immune globulin for the newborn mediated through improved placental health and function? Clin Infect Dis 2006; 43:1001-1003.
47. Broeder JA, Smith CH, Moe AJ. Glutamate oxidation by trophoblasts in vitro. Am J Physiol 1994; 267:C189-C194.
48. Compton T. Receptors and immune sensors: the complex entry path of human cytomegalovirus. Trends Cell Biol 2004; 14:5-8.
49. Griffith BP, Chen M, Isom HC. Role of primary and secondary maternal viremia in transplacental guinea pig cytomegalovirus transfer. J Virol 1990; 64:1991-1997.
50. Schleiss MR. Animal models of congenital cytomegalovirus infection: an overview of progress in the characterization of guinea pig cytomegalovirus (GPCMV). J Clin Virol 2002; 25(suppl 2):S37-S49.
51. Boyd JD, Hamilton WJ. Electron miscroscopic observations on the cytotrophoblast contribution to the syncytium in the human placenta. J Anat 1966; 100:535-548.
52. Dreyfuss JL, Regatieri CV, Jarrouge TR, Cavalheiro RP, Sampaio LO, Nader HB. Heparan sulfate proteoglycans: structure, protein interactions and cell signaling. An Acad Bras Cienc 2009; 81:409-429.
53. Fortunato EA, McElroy AK, Sanchez I, Spector DH. Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol 2000; 8:111-119.
54. Speir E, Shibutani T, Yu ZX, Ferrans V, Epstein SE. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ Res 1996; 79:1143-1152.
55. Trincado DE, Munro SC, Camaris C, Rawlinson WD. Highly sensitive detection and localization of maternally acquired human cytomegalovirus in placental tissue by in situ polymerase chain reaction. J Infect Dis 2005; 192:650-657.
56. Maidji E, Percivalle E, Gerna G, Fisher S, Pereira L. Transmission of human cytomegalovirus from infected uterine microvascular endothelial cells to differentiating/invasive placental cytotrophoblasts. Virology 2002; 304:53-69.
57. Hemmings DG, Guilbert LJ. Polarized release of human cytomegalovirus from placental trophoblasts. J Virol 2002; 76:6710-6717.
58. Chaudhuri S, Lowen B, Chan G, Davey A, Riddell M, Guilbert LJ. Human cytomegalovirus interacts with toll-like receptor 2 and CD14 on syncytiotrophoblasts to stimulate expression of TNFalpha mRNA and apoptosis. Placenta 2009; 30:994-1001.
59. Maidji E, McDonagh S, Genbacev O, Tabata T, Pereira L. Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol 2006; 168:1210- 1226.